N-3 polyunsaturated fatty acids in psychiatric diseases: Mechanisms and clinical data

Neuroendocrinology Letters

Volumn 33, Issue 8, 2012, Pages 736-748

  Zeman, Miroslav ^a   Jirák, Roman ^a   Vecka, Marek ^a   Raboch, Jiří ^a   Žák, Aleš ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Arachidonic acid; Depression; Docosahexaenoic acid; Docosanoids; Eicosanoids; Psychiatric disease

Indexed keywords

ADIPONECTIN; ALPHA SECRETASE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ARACHIDONIC ACID; BETA SECRETASE; BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; DOCOSAHEXAENOIC ACID; ENDOCANNABINOID; FISH OIL; HOMOCYSTEIC ACID; ICOSAPENTAENOIC ACID; LEPTIN; LIPID; MELATONIN; NEUROTRANSMITTER; OMEGA 3 FATTY ACID; OXYLIPIN; PLACEBO;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; BRAIN METABOLISM; CELL MEMBRANE; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; COGNITION; DEPRESSION; DNA METHYLATION; DRUG DOSE TITRATION; DRY WEIGHT; FAT INTAKE; HUMAN; IMMUNOMODULATION; INFLAMMATION; LIPID BILAYER; MAJOR DEPRESSION; MENTAL DISEASE; META ANALYSIS (TOPIC); MICROGLIA; NERVE CELL; NERVE CELL MEMBRANE; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROTRANSMISSION; NITROSATIVE STRESS; NONHUMAN; NUTRITIONAL DEFICIENCY; OMEGA 3 FATTY ACID DEFICIENCY; OXIDATIVE STRESS; PHYSICAL CHEMISTRY; PUERPERAL DEPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 84874808865     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (145)

1. Abdolmaleky HM, Cheng KH, Faraone SV, Wilcox M, Glatt SJ, Gao F, Smith CL, Shafa R, Aeali B, Carnevale J, Pan H, Papageorgis P, Ponte JF, Sivaraman V, Tsuang MT, Thiagalingam S (2006). Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet. 15(21): 3132-45. (Pubitemid 44607800)
2. Adams PB, Lawson S, Sanigorski A, Sinclair AJ (1996). Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 31 Suppl: S157-61
3. Amminger GP, Schäfer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, Mackinnon A, McGorry PD, Berger GE (2010). Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 67(2): 146-54.
4. Anderson G, Maes M (2012). Schizophrenia: Linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression. Prog Neuropsychopharmacol Biol Psychiatry. http://dx.doi.org/10.1016/j.pnpbp.2012.07.016.
5. Antalis CJ, Stevens U, Campbell M, Pazdro R, Ericson K, Burgess JR (2006). Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids. 75(4-5): 299-308. (Pubitemid 44442911)
6. Appleton KM, Rogers PJ, Ness AR (2010).Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr 91(3): 757-70.
7. Arterburn LM, Hall EB, Oken H (2006). Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr. 83(6 Suppl): 1467S-1476S (Pubitemid 44713087)
8. Banks WA, Coon AB, Robinson SM, Moinuddin A, Shultz JM, Nakaoke R, Morley JE (2004). Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes 53(5): 1253-60. (Pubitemid 38569011)
9. Barberger-Gateau P, Raffaitin C, Letenneur L, Berr C, Tzourio C, Dartigues JF, Alpérovitch A (2007). Dietary patterns and risk of dementia: the Three-City cohort study. Neurology. 69(20): 1921-30. (Pubitemid 350100350)
10. Bazan NG (2009). Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease. J Lipid Res 50: S400-S405.
11. Bazan NG, Colangelo V, Lukiw WJ (2002). Prostaglandins and other lipid mediators in Alzheimer's disease. Prostaglandins Other Lipid Mediat 68-69: 197-210. (Pubitemid 35247397)
12. Bloch MH, Qawasmi A (2011). Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry 50(10): 991-1000.
13. Bosetti F (2007). Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse models. J Neurochem. 102(3): 577-86.
14. Bottiglieri T, Laundy M, Crellin R, Toone BK, Carney MW, Reynolds EH (2000). Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry. 69(2): 228-32 (Pubitemid 30466029)
15. Bourre JM, Dumont O, Piciotti M, Clément M, Chaudière J, Bonneil M, Nalbone G, Lafont H, Pascal G, Durand G (1991). Essentiality of omega 3 fatty acids for brain structure and function. World Rev Nutr Diet 66: 103-17.
16. Bousquet M, Gibrat C, Saint-Pierre M, Julien C, Calon F, Cicchetti F (2009). Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model. Prog Neuropsycho-pharmacol Biol Psychiatry. 33(8): 1401-8.
17. Browne JC, Scott KM, Silvers KM (2006). Fish consumption in pregnancy and omega-3 status after birth are not associated with postnatal depression. J Affect Disord 90(2-3): 131-9. Epub 2005 Dec 1.
18. Calderon F, Kim HY (2004). Docosahexaenoic acid promotes neurite growth in hippocampal neurons J Neurochem 90(4): 979-88. (Pubitemid 39099980)
19. Carver JD, Benford VJ, Han B, Cantor AB (2001). The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects. Brain Res Bull 56(2): 79-85. (Pubitemid 33028885)
20. Catalá A (2010). The function of very long chain polyunsaturated fatty acids in the pineal gland. Biochim Biophys Acta. 1801(2): 95-9.
21. Colter AL, Cutler C, Meckling KA (2008). Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study. Nutr J. 14;7: 8.
22. Conklin SM, Gianaros PJ, Brown SM, Yao JK, Hariri AR, Manuck SB, Muldoon MF (2007). Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neurosci Lett. 421 (3): 209-12. (Pubitemid 46935357)
23. Conklin SM, Manuck SB, Yao JK, Flory JD, Hibbeln JR, Muldoon MF (2007). High omega-6 and low omega-3 fatty acids are associated with depressive symptoms and neuroticism. Psychosom Med. 69(9): 932-4. (Pubitemid 350158836)
24. Cysneiros RM, Ferrari D, Arida RM, Terra VC, de Almeida AC, Cavalheiro EA, Scorza FA (2010). Qualitative analysis of hippocampal plastic changes in rats with epilepsy supplemented with oral omega-3 fatty acids. Epilepsy Behav 17(1): 33-8
25. De Vriese SR, Christophe AB, Maes M (2003). Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. Life Sci 73(25): 3181-7. (Pubitemid 37242978)
26. Deckelbaum RJ, Worgall TS, Seo T (2006). n-3 fatty acids and gene expression. Am J Clin Nutr 83(6 Suppl): 1520S-1525S (Pubitemid 44713093)
27. Delion S, Chalon S, Hérault J, Guilloteau D, Besnard JC, Durand G (1994). Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. J Nutr 124: 2466-76.
28. DeMar JC Jr, Ma K, Bell JM, Igarashi M, Greenstein D, Rapoport SI (2006). One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. J Lipid Res. 47(1): 172-80. Epub 2005 Oct 6
29. Dittmann S, Seemüller F, Schwarz MJ, Kleindienst N, Stampfer R, Zach J, Born C, Bernhard B, Fast K, Grunze H, Engel RR, Severus E (2007). Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results. Bipolar Disord 9(1-2): 63-70. (Pubitemid 46671675)
30. Doggett AM (2004). ADHD and drug therapy: is it still a valid treatment? J Child Health Care 8: 69-81.
31. Drtílková I., Theiner P (2008). Clinical and Biological Markers of Persistent Form of Hyperkinetic Disorder (ADHD). Čes. a slov. Psychiat. 104: 167-171.(In Czech)
32. Edwards R, Peet M, Shay J, Horrobin D (1998). Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 48(2-3): 149-55. (Pubitemid 28244216)
33. Ekdahl CT, Claasen JH, Bonde S, Kokaia Z, Lindvall O (2003). Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci U S A 100(23): 13632-7. (Pubitemid 37444791)
34. Faldella G, Govoni M, Alessandroni R, Marchiani E, Salvioli GP, Biagi PL, Spano C (1996). Visual evoked potentials and dietary long chain polyunsaturated fatty acids in preterm infants. Arch Dis Child 75: F108-F112.
35. Féart C, Peuchant E, Letenneur L, Samieri C, Montagnier D, Fourrier-Reglat A, Barberger-Gateau P (2008). Plasma eicosapentaenoic acid is inversely associated with severity of depressive symptomatology in the elderly: data from the Bordeaux sample of the Three-City Study. Am J Clin Nutr. 87(5): 1156-62. (Pubitemid 351679753)
36. Fernandez-Ruiz J, Hernández M, Ramos JA (2010) Cannabinoid-Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders. CNS Neuroscience & Therapeutics 16 : e72-e91
37. Fitzpatrick FA, Soberman R (2001). Regulated formation of eicosanoids J Clin Invest 107: 1347-1351. (Pubitemid 32522026)
38. Flachs P, Mohamed-Ali V, Horakova O, Rossmeisl M, Hosseinzadeh-Attar MJ, Hensler M, Ruzickova J, Kopecky J (2006). Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia. 49(2): 394-7. (Pubitemid 43185410)
39. Folstein M, Liu T, Peter I, Buell J, Arsenault L, Scott T, Qiu WW (2007). The homocysteine hypothesis of depression. Am J Psychiatry. 164(6): 861-7. (Pubitemid 46978110)
40. Fornaro M, Prestia D, Colicchio S, Perugi G (2010). A Systematic, Updated Review on the Antidepressant Agomelatine Focusing on its Melatonergic Modulation. Current Neuropharmacology 8: 287-304.
41. Frangou S, Lewis M, McCrone P (2006). Efficacy of ethyl-eicos-apentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry 188: 46-50. (Pubitemid 43021926)
42. Frasure-Smith N, Lespérance F, Julien P (2004). Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol Psychiatry 55(9): 891-6. (Pubitemid 38526301)
43. Freund-Levi Y, Basun H, Cederholm T, Faxén-Irving G, Garlind A, Grut M, Vedin I, Palmblad J, Wahlund LO, Eriksdotter-Jönhagen M (2008). Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms. Int J Geriatr Psychiatry. 23(2): 161-9. (Pubitemid 351308496)
44. Fukuzako H, Fukuzako T, Hashiguchi T, Kodama S, Takigawa M, Fujimoto T (1999). Changes in levels of phosphorus metabolites in temporal lobes of drug-naive schizophrenic patiens. Am J Psychiatry. 156(8): 1205-8. (Pubitemid 29374880)
45. Gerbi A, Maixent JM, Barbey O, Jamme I, Pierlovisi M, Coste T, et al (1998). Alterations of Na, K-ATPase isoenzymes in the rat diabetic neuropathy: protective effect of dietary supplementation with n-3 fatty acids. J Neurochem 71: 732-740. (Pubitemid 28480421)
46. Golding J, Steer C, Emmett P, Davis JM, Hibbeln JR (2009). High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fis. Epidemiology. 20(4): 598-603.
47. Hankey GJ, Eikelboom JW (1999). Homocysteine and vascular disease. Lancet 354: 407-13. (Pubitemid 29355767)
48. Harris WS (1989). Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res. 30(6): 785-807.
49. Hashimoto M, Hossain S, Shimada T, Sugioka K, Yamasaki H, Fujii Y, Ishibashi Y, Oka J, Shido O (2002). Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J Neurochem. 81(5): 1084-91. (Pubitemid 34809291)
50. Hashimoto M, Shahdat HM, Yamashita S, Katakura M, Tanabe Y, Fujiwara H, Gamoh S, Miyazawa T, Arai H, Shimada T, Shido O (2008). Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats. J Neurochem. 107(6): 1634-46.
51. Henderson DC, Copeland PM, Nguyen DD, Borba CP, Cather C, Eden Evins A, Freudenreich O, Baer L, Goff DC (2006). Homocysteine levels and glucose metabolism in non-obese, non-diabetic chronic schizophrenia. Acta Psychiatr Scand 113(2): 121-125. (Pubitemid 43340905)
52. Hernell O, Holmgren G, Jagell SF, Johnson SB, Holman RT (1982). Suspected faulty essential fatty acid metabolism in Sjogren-Larsson syndrome. Pediatr Res 16: 45-49. (Pubitemid 12200710)
53. Hibbeln JR (1998). Fish consumption and major depression. Lancet 351: 1213.
54. Hichami A, Morin C, Rousseau E, Khan NA (2005).: Diacylgiycerol-Containing Docosahexaenoic Acid in Acyl Chain Modulates Airway Smooth Muscle Tone. Amer J Resp Cell Mol Biol 33: 378-386. (Pubitemid 41416288)
55. Holman RT, Johnson SB, Ogburn PL (1991). Deficiency of essential fatty acids and membrane fluidity during pregnancy and lactation. Proc Natl Acad Sci U S A. 88(11): 4835-9. (Pubitemid 21914637)
56. Horrobin DF, Manku MS, Hillman H, Iain A, Glen M. Fatty acid levels in the brains of schizophrenics and normal controls. Biol Psychiatry. 1991 Oct 15;30(8): 795-805.
57. Huang T, Wahlqvist ML, Li D (2012). Effect of n-3 polyunsaturated fatty acid on gene expression of the critical enzymes involved in homocysteine metabolism. Nutr J. 11(1): 6. [Epub ahead of print]
58. Chahl LA (2011). TRP channels and psychiatric disorders. Adv Exp Med Biol 704: 987-1009.
59. Chalon S (2006). Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids. 75(4-5): 259-69.
60. Charnay Y, Cusin I, Vallet PG, Muzzin P, Rohner-Jeanrenaud F, Bouras C (2000). Intracerebroventricular infusion of leptin decreases serotonin transporter binding sites in the frontal cortex of the rat. Neurosci Lett 283(2): 89-92. (Pubitemid 30156740)
61. Jans LA, Giltay EJ, Van der Does AJ (2010). The efficacy of n-3 fatty acids DHA and EPA (fish oil) for perinatal depression. Br J Nutr 104(11): 1577-85.
62. Jicha GA, Markesbery WR (2010). Omega-3 fatty acids: potential role in the management of early Alzheimer's disease. Clin Interv Aging. 5: 45-61.
63. Johnson EJ, Schaefer EJ (2006). Potential role of dietary n-3 fatty acids in the prevention of dementia and macular degeneration. Am J Clin Nutr. 83(6 Suppl): 1494S-1498S. (Pubitemid 44713090)
64. Kearns SD, Haag M (2002). The effect of omega-3 fatty acids on Ca-ATPase in rat cerebral cortex. Prostaglandins Leukot Essent Fatty Acids 67: 303-8. (Pubitemid 35397370)
65. Kennedy BP, Bottiglieri T, Arning E, Ziegler MG, Hansen LA, Masliah E (2004). Elevated S-adenosylhomocysteine in Alzheimer brain: influence on methyltransferases and cognitive function. J Neural Transm. 111(4): 547-67. (Pubitemid 38478922)
66. Keshavan MS, Stanley JA, Pettegrew JW (2000). Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings - part II. Biol Psychiatry 48(5): 369-80.
67. Kidd PM (2008). Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. Altern Med Rev 13(2): 85-115.
68. Kitajka K, Puskás LG, Zvara A, Hackler L Jr, Barceló-Coblijn G, Yeo YK, Farkas T (2002). The role of n-3 polyunsaturated fatty acids in brain: modulation of rat brain gene expression by dietary n-3 fatty acids. Proc Natl Acad Sci U S A. 99(5): 2619-24. (Pubitemid 34240510)
69. Kodydková J, Vávrová L, Zeman M, Jirák R, Macášek J, Stanková B, Tvrzická E, Žák A (2009). Antioxidative enzymes and increased oxidative stress in depressive women. Clin Biochem. 42(13-14): 1368-74.
70. Leonelli M, Graciano MFR. Britto LRG (2011). TRP channels, omega-3 fatty acids, and oxidative stress in neurodegeneration: from the cell membrane to intracellular cross-links. Braz J Med Biol Res 44(11): 1088-1096.
71. Li D, Yu XM, Xie HB, Zhang YH, Wang Q, Zhou XQ, Yu P, Wang LJ (2007). Platelet phospholipid n-3 PUFA negatively associated with plasma homocysteine in middle-aged and geriatric hyperlipaemia patients. Prostaglandins Leukot Essent Fatty Acids. 76(5): 293-7. (Pubitemid 46803263)
72. Liu Z, Wang D, Xue Q, Chen J, Li Y, Bai X, Chang L (2003). Determination of fatty acid levels in erythrocyte membranes of patients with chronic fatigue syndrome. Nutritional neuroscience 6: 389-92. (Pubitemid 38072539)
73. Lorente-Cebrián S, Pérez-Matute P, Martínez JA, Marti A, Moreno-Aliaga MJ (2006). Effects of eicosapentaenoic acid (EPA) on adiponectin gene expression and secretion in primary cultured rat adipocytes. J Physiol Biochem 62(2): 61-9.
74. Lu XY (2007). The leptin hypothesis of depression: a potential link between mood disorders and obesity? Curr Opin Pharmacol. 7(6): 648-52.
75. Ma QL, Teter B, Ubeda OJ, Morihara T, Dhoot D, Nyby MD, Tuck ML, Frautschy SA, Cole GM (2007). Omega-3 fatty acid docosahexaenoic acid increases SorLA/LR11, a sorting protein with reduced expression in sporadic Alzheimer's disease (AD): relevance to AD prevention. J Neurosci. 27(52): 14299-307.
76. Maes M (2009). Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms. Curr Opin Psychiatry 22: 75-83.
77. Maes M, Fišar Z, Medina M, Scapagnini G, Nowak G, Berk M (2012). New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates-Nrf2 activators and GSK-3 inhibitors Inflammopharmacol 20: 127-150.
78. Maes M, Galecki P, Chang YS, Berk M (2011 b). A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro) degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry 35: 676-692.
79. Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY (1998). Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesterol esters of depressed patients. Psychiatry Res. 85(3): 275-91.
80. Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J (2011a). Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. Neuro Endocrinol Lett 32(1): 7-24.
81. Maes M, Mihaylova I, Leunis JC (2005). In chronic fatigue syndrome, the decreased levels of omega-3 poly-unsaturated fatty acids are related to lowered serum zinc and defects in T cell activation. Neuro Endocrinol. Lett. 26: 745-51.
82. Maes M, Smith R, Christophe A, Cosyns P, Desnyder R, Meltzer H (1996). Fatty acid composition in major depression: Decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20: 5 omega 3 ratio in cholesteryl esters and phospholipids. J Affective Disord 38: 35-46.
83. Maes M, Smith RS (1998). Fatty acids, cytokines, and major depression. Biol Psychiatry 43(5): 313-4.
84. Mahadik SP, Evans DR (2003). Is schizophrenia a metabolic brain disorder? Membrane phospholipid dysregulation and its therapeutic implications. Psychiatr Clin N Am 26: 85-102 (Pubitemid 36384349)
85. Mamalakis G, Kalogeropoulos N, Andrikopoulos N, Hatzis C, Kromhout D, Moschandreas J, Kafatos A (2006). Depression and long chain n-3 fatty acids in adipose tissue in adults from Crete. Eur J Clin Nutr 60(7): 882-888. (Pubitemid 43997701)
86. Marszalek JR, Lodish HF (2005). Docosahexaenoic acid, fatty acid-interacting proteins, and neuronal function: breastmilk and fish are good for you. Annu Rev Cell Dev Biol 21: 633-57. (Pubitemid 41740649)
87. McNamara RK, Carlson SE (2006). Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopatology Prostaglandins Leukot Essent Fatty Acids 75(4-5): 329-49. (Pubitemid 44442917)
88. McNamara RK, Hahn CG, Jandacek R, Rider T, Tso P, Stanford KE, Richtand NM (2007). Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol Psychiatry. 62(1): 17-24. (Pubitemid 46898224)
89. McNamara RK, Jandacek R (2011). Investigation of postmortem brain polyunsaturated fatty acid composition in psychiatric disorders: limitations, challenges, and future directions. J Psychiatr Res 45(1): 44-6.
90. McNamara RK, Jandacek R, Rider T, Tso P, Cole-Strauss A, Lipton JW (2010). Omega-3 fatty acid deficiency increases constitutive pro-inflammatory cytokine production in rats: relationship with central serotonin turnover. Prostaglandins Leukot Essent Fatty Acids. 83(4-6): 185-91.
91. Miller AL (2008). The methylation, neurotransmitter, and antioxidant connections between folate and depression. Altern Med Rev. 13(3): 216-26.
92. Minami M, Kimura S, Endo T, Hamaue N, Hirafuji M, Togashi H, Matsumoto M, Yoshioka M, Saito H, Watanabe S, Kobayashi T, Okuyama H (1997). Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats. Pharmacol Biochem Behav 58: 1123-1129. (Pubitemid 28108225)
93. Moore SA, Hurt E, Yoder E, Sprecher H, Spector AA (1995). Docosahexaenoic acid synthesis in human skin fibroblasts involves peroxisomal retroconversion of tetracosahexaenoic acid. J Lipid Res 36: 2433-2443.
94. Mourek J, Langmeier M, Pokorny J (2009). Significance of the plasma membrane for the nerve cell function, development and plasticity. Neuro Endocrinol Lett 30(6): 694-699.
95. Moylan S, Maes M, Wray NR, Berk M (2012). The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry. 2012 Apr 24. doi: 10.1038/mp.2012.33.
96. Murphy MG (1990). Dietary fatty acids and membrane protein function. J. Nutr. Biochem 1: 68-79.
97. Narayanan BA, Narayanan NK, Reddy BS (2001). Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells. Int J Oncol 19(6): 1255-62.
98. Pandya CD, Howell KR, Pillai A (2012). Antioxidants as potential therapeutics for neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry, http://dx.doi.org/10.1016/j.pnpbp.2012.07.017
99. Paz-Filho G, Wong ML, Licinio J (2010). The procognitive effects of leptin in the brain and their clinical implications. Int J Clin Pract 64(13): 1808-12.
100. Peet M, Murphy B, Shay J, Horrobin D (1998). Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry; 43(5): 315-9. (Pubitemid 28137622)
101. Peet M, Shah S, Selvam K., Ramchand CN (2004). Polyunsaturated fatty acid levels in red cell membranes of unmedicated schizophrenic patiens. World J Biol Psychiatry 5: 92-99.
102. Peyron-Caso E, Taverna M, Guerre-Millo M, Veronese A, Pacher N, Slama G, Rizkalla S (2002). Dietary (n-3) polyunsaturated fatty acids upregulate plasma leptin in insulin-resistant rats J Nutr 132: 2235-2240. (Pubitemid 34851656)
103. Pike LJ (2004). Lipid rafts: heterogeneity on the high seas. Biochem J 384: 281-292.
104. Puri BK (2004). The use of eicosapentaenoic acid in the treatment of chronic fatigue syndrome. Prostaglandins Leukot Essent Fatty Acids 70: 399-401.
105. Puri BK, Counsell SJ, Hamilton G (2008). Brain cell membrane motion-restricted phospholipids: a cerebral 31-phosphorus magnetic resonance spectroscopy study of patients with schizophrenia. Prostaglandins Leukot Essent Fatty Acids. 79(6): 233-5.
106. Rabaneda LG, Carrasco M, López-Toledano MA, Murillo-Carretero M, Ruiz FA, Estrada C, Castro C (2008). Homocysteine inhibits proliferation of neuronal precursors in the mouse adult brain by impairing the bFGF signaling cascade and reducing Erk1/2-dependent cyclin E expression. FASEB J 22: 3823-3835.
107. Ravaglia G, Forti P, Maioli F, Muscari A, Sacchetti L, Arnone G, Nativio V, Talerico T, Mariani E (2003). Homocysteine and cognitive function in healthy elderly community dwellers in Italy. Am. J. Clin. Nutr 77: 668-673. (Pubitemid 36258578)
108. Reddy KS, Katan MB (2004). Diet, nutrition and the prevention of hypertension and cardiovascular diseases. Public Health Nutr. 7(1A): 167-86. (Pubitemid 38294516)
109. Reisbick S, Neuringer M, Connor W, Iliff-Sizemore S (1990b). Increased intake of water and NaCl solutions in omega-3 fatty acid deficient monkeys. Physiol Behav 49: 1139-1146.
110. Reisbick S, Neuringer M, Hasnain R, Connor W (1990a). Polydipsia in rhesus monkeys deficient in omega-3 fatty acids. Physiol Behav 47: 315-323. (Pubitemid 20098009)
111. Reiter RJ, Tan DX, Jou MJ, Korkmaz A, Manchester LC, Paredes SD (2008). Biogenic amines in the reduction of oxidative stress: melatonin and its metabolites. Neuro Endocrinol Lett. 29(4): 391-8.
112. Richardson TJ, Sgoutas D (1975). Essential fatty acid deficiency in four adult patients during total parenteral nutrition. Am J Clin Nutr 28: 258-263.
113. Ross BM, Seguin J, Sieswerda LE (2007). Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? Lipids in Health and Disease 6: 21 doi: 10.1186/1476-511X-6-21
114. Ross BM, Turenne S, Moszczynska A, Warsh JJ, Kish SJ (1999). Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia. Brain Res 821(2): 407-13. (Pubitemid 29222805)
115. Rossi AS, Lombardo YB, Lacorte JM, Chicco AG, Rouault C, Slama G, Rizkalla SW (2005). Dietary fish oil positively regulates plasma leptin and adiponectin levels in sucrose-fed, insulin-resistant rats. Am J Physiol Regul Integr Comp Physiol 289(2): R486-R494. (Pubitemid 41060504)
116. Sanders P, Korf J (2008). Neuroaetiology of chronic fatigue syndrome: an overview. World J Biol. Psychiatry 9: 165-71
117. Sardesai VM (1992). The essential fatty acids. Nutr Clin Pract 7: 179-186.
118. Sarris J, Mischoulon D, Schweitzer I (2011). Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials. Bipolar Disord. 13(5-6): 454-65. doi: 10.1111/j.1399-5618.2011.00945.x.
119. Serhan CN, Krishnamoorthy S, Recchiuti A, Chiang N (2011). Novel Anti-Inflammatory - Pro-Resolving Mediators and Their Receptors Curr Top Med Chem 11(6): 629-647.
120. Shahbakhti H, Watson RE, Azurdia RM, Ferreira CZ, Garmyn M, Rhodes LE (2004). Influence of eicosapentaenoic acid, an omega-3 fatty acid, on ultraviolet-B generation of prostaglandin-E2 and proinflammatory cytokines interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 in human skin in vivo. Photochem Photobiol 80(2): 231-5.
121. Shimazawa M, Nakajima Y, Mashima Y, Hara H (2009). Docosahexaenoic acid (DHA) has neuroprotective effects against oxidative stress in retinal ganglion cells. Brain Res 1251: 269-75
122. Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, Tucker KL, Kyle DJ, Wilson PW, Wolf PA (2006). Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol 63(11): 1545-50. (Pubitemid 44748796)
123. Signorini C, Ciccoli L, Leoncini S, Carloni S, Perrone S, Comporti M, Balduini W, Buonocore G (2009).Free iron, total F-isoprostanes and total F-neuroprostanes in a model of neonatal hypoxic-ischemic encephalopathy: neuroprotective effect of melatonin. J Pineal Res 46(2): 148-54.
124. Siguel E (1994). Essential Fatty Acids in Health and Disease. Nutrek Press: Brookline, MA.
125. Siguel E, Lerman R (1996). Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders. Metabolism 45: 12-23. (Pubitemid 26104262)
126. Simopoulos AP (1999). Essential fatty acids in health and chronic disease. Am J Clin Nutr. 70(3 Suppl): 560S-569S.
127. Simopoulos AP (2008) Nutrition and fitness: cultural, genetic and metabolic aspects. World Rev Nutr Diet 98: IX-XV.
128. Sorgi PJ, Hallowell EM, Hutchins HL, Sears B (2007). Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder. Nutr J 6: 16.
129. Stevens LJ, Zentall SS, Abate ML, Kuczek T, Burgess JR (1996). Omega-3 fatty acids in boys with behavior, learning, and health problems. Physiol Behav 59: 915-920. (Pubitemid 26110718)
130. Stinson AM, Wiegand RD, Anderson RE (1991). Fatty acid and molecular species compositions of phospholipids and diacylglycerols from rat retinal membranes. Exp.Eye Res 52: 213-218.
131. Stoll AL, Locke CA, Marangell LB, Severus WE (1999). Omega-3 fatty acids and bipolar disorder: a review.Prostaglandins Leukot Essent Fatty Acids. 60(5-6): 329-37. (Pubitemid 29401788)
132. Sublette ME, Russ MJ, Smith GS (2004). Evidence for a role of the arachidonic acid cascade in affective disorders: a review. Bipolar Disord 6: 95-105 (Pubitemid 38443562)
133. Tiemeier H, van Tuijl HR, Hofman A, Kiliaan AJ, Breteler MM (2003). Plasma fatty acid composition and depression are associated in the elderly: The Rotterdam study. Am J Clin Nutr 78: 40-46. (Pubitemid 39655246)
134. Vancassel S, Leman S, Hanonick L, Denis S, Roger J, Nollet M, Bodard S, Kousignian I, Belzung C, Chalon S (2008). n-3 polyunsaturated fatty acid supplementation reverses stress-induced modifications on brain monoamine levels in mice. J Lipid Res 49: 340-8. (Pubitemid 351213618)
135. Wainwright P (2000). Nutrition and behaviour: the role of n-3 fatty acids in cognitive function. Br J Nutr 83(4): 337-9.
136. Warren G, Mckendrick M, Peet M (1999). The role of essential fatty acids in chronic fatigue syndrome. A case-controlled study of red-cell membrane essential fatty acids (EFA) and a placebo-controlled treatment study with high dose of EFA. Acta Neurol Scand 99: 112-6. (Pubitemid 29064317)
137. Williard DE, Nwankwo JO, Kaduce TL, Hormon SD, Irons M, Moser HW, Raymond GV, Spector AA (2001). Identification of a fatty acid D6 desaturase deficiency in human skin fibroblasts. J Lipid Res 42: 501-508.
138. Wozniak J, Biederman J, Mick E, Waxmonsky J, Hantsoo L, Best C, Cluette-Brown JE, Laposata M (2007). Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trial. Eur Neuropsychopharmacol. 17(6-7): 440-7. (Pubitemid 46497662)
139. Yao JK, van Kammen DP (2004). Membrane phospholipids and cytokine interaction in schizophrenia. Int Rev Neurobiol 59: 297-326. (Pubitemid 39753905)
140. Young G, Conquer J (2005). Omega-3 fatty acids and neuropsychiatric disorders. Reprod Nutr Dev. 45(1): 1-28. (Pubitemid 40528530)
141. Zeman M, Jirák R, Jáchymová M, Vecka M, Tvrzická E, Žák A (2009). Leptin, adiponectin, leptin to adiponectin ratio and insulin resistance in depressive women. Neuro Endocrinol Lett 30(3): 387-95.
142. Zeman M, Žák A, Vecka M, Tvrzická E, Písaříková A, Staňková B (2006). N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statinfibrate combination. J Nutr Biochem 17(6): 379-84. (Pubitemid 43729351)
143. Zhang CE, Wei W, Liu YH, Peng JH, Tian Q, Liu GP, Zhang Y, Wang JZ (2009). Hyperhomocysteinemia Increases β-Amyloid by Enhancing Expression of γ-Secretase and Phosphorylation of Amyloid Precursor Protein in Rat Brain. Am J Pathol 174: 1481-1491.
144. Zimmer L., Vancassel S., Cantagrel S., Breton P, Delamanche S, Guilloteau D, et al (2002). The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids. Am J Clin Nutr 75(4): 662-667. (Pubitemid 34250678)
145. Žák A, Hátle K, Mareš P, Vrána A, Zeman M, Šindelková E, Skořepa J, Hrabák P (1990). Effects of dietary n-3 fatty acids on the composition of cholesteryl esters and triglycerides in plasma and liver perfusate of the rat. J Nutr Biochem 1(9): 472-7.